Isoniazid-associated hepatitis in 114 patients.

PubWeight™: 2.02‹?› | Rank: Top 2%

🔗 View Article (PMID 1150039)

Published in Gastroenterology on August 01, 1975

Authors

M Black, J R Mitchell, H J Zimmerman, K G Ishak, G R Epler

Associated clinical trials:

Using Entecavir to Reduce Hepatitis in Highly Viremic HBV Patients During Anti-tuberculous Treatment (HBV) | NCT01724723

Articles citing this

Drug-induced autoimmune-like hepatitis. Dig Dis Sci (2011) 2.86

Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study. Gastroenterology (2015) 2.43

Adverse events associated with treatment of latent tuberculosis in the general population. CMAJ (2011) 1.58

N-acetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and Denmark. Environ Health Perspect (1979) 1.43

Pathologic aspects of cirrhosis. A review. Am J Pathol (1977) 1.41

CYP2E1 genotype and isoniazid-induced hepatotoxicity in patients treated for latent tuberculosis. Eur J Clin Pharmacol (2006) 1.25

Hepatotoxicity to sodium valproate: a review. Gut (1984) 1.24

Roles of rifampicin in drug-drug interactions: underlying molecular mechanisms involving the nuclear pregnane X receptor. Ann Clin Microbiol Antimicrob (2006) 1.23

Drug-induced liver injury: is it somehow foreseeable? World J Gastroenterol (2009) 1.18

Isoniazid-related fatal hepatitis. West J Med (1996) 1.17

Isoniazid preventive therapy, hepatitis C virus infection, and hepatotoxicity among injection drug users infected with Mycobacterium tuberculosis. Clin Infect Dis (2001) 1.13

Isoniazid and action tremor in multiple sclerosis. J Neurol Neurosurg Psychiatry (1985) 1.11

Direct oxidation and covalent binding of isoniazid to rodent liver and human hepatic microsomes: humans are more like mice than rats. Chem Res Toxicol (2012) 1.09

Idiosyncratic drug-induced liver injury and the role of inflammatory stress with an emphasis on an animal model of trovafloxacin hepatotoxicity. Toxicol Sci (2010) 1.06

The role of biotransformation in chemical-induced liver injury. Environ Health Perspect (1976) 0.98

Evaluation of prognostic markers in severe drug-induced liver disease. World J Gastroenterol (2007) 0.94

Detection of anti-isoniazid and anti-cytochrome P450 antibodies in patients with isoniazid-induced liver failure. Hepatology (2014) 0.93

Hepatotoxic effects of therapies for tuberculosis. Nat Rev Gastroenterol Hepatol (2010) 0.92

Evaluation of isoniazid-associated hepatitis by immunological tests. Clin Exp Immunol (1978) 0.88

Eosinophils mediate the pathogenesis of halothane-induced liver injury in mice. Hepatology (2013) 0.88

Antituberculosis treatment-induced hepatotoxicity: role of predictive factors. Postgrad Med J (1995) 0.87

Antitubercular therapy in patients with cirrhosis: challenges and options. World J Gastroenterol (2014) 0.86

Isoniazid liver injury during chemoprophylaxis in children. Arch Dis Child (1979) 0.86

Mechanisms of adaptation and progression in idiosyncratic drug induced liver injury, clinical implications. Liver Int (2015) 0.86

Hepatic reactions to drugs. Gut (1979) 0.85

Serial study of clinical and CT changes in tuberculous meningitis. Neuroradiology (2003) 0.85

CYP2E1-dependent elevation of serum cholesterol, triglycerides, and hepatic bile acids by isoniazid. Toxicol Appl Pharmacol (2012) 0.84

Late effects following isoniazid therapy. Am J Public Health (1980) 0.83

Mechanism of isoniazid-induced hepatotoxicity: then and now. Br J Clin Pharmacol (2016) 0.81

Isoniazid hepatotoxicity requiring liver transplantation. Dig Dis Sci (2014) 0.80

Risk Factors of Hepatotoxicity During Anti-tuberculosis Treatment. Med J Armed Forces India (2011) 0.79

Isoniazid metabolism and hepatotoxicity. Acta Pharm Sin B (2016) 0.79

Clinicopathological correlates in HIV seropositive tuberculosis cases presenting with jaundice after initiating antiretroviral therapy with a structured review of the literature. BMC Infect Dis (2012) 0.78

A study of the effect of Nigella sativa (Black seeds) in isoniazid (INH)-induced hepatotoxicity in rabbits. Indian J Pharmacol (2012) 0.77

Portal fibrosis in the livers of alcoholic patients. Gut (1978) 0.76

Piroxicam induced submassive necrosis of the liver. Gut (1992) 0.76

Isoniazid hepatotoxicity: progress in understanding the immunologic component. Hepatology (2014) 0.75

Interplay of factors leading to adverse drug reactions in the liver, a personal viewpoint. Yale J Biol Med (1978) 0.75

Drug hepatotoxicity. Br J Clin Pharmacol (1983) 0.75

Lymphocyte-mediated cytotoxicity in isoniazid-associated hepatitis. Clin Exp Immunol (1979) 0.75

Hepatic manifestations of non-steroidal inflammatory bowel disease therapy. World J Hepatol (2015) 0.75

Research challenges, new drug development, preclinical and clinical trials in the ageing population. Drug Saf (1990) 0.75

Articles by these authors

DNA primers for amplification of mitochondrial cytochrome c oxidase subunit I from diverse metazoan invertebrates. Mol Mar Biol Biotechnol (1994) 49.81

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology (1982) 11.24

Relative contributions of history-taking, physical examination, and laboratory investigation to diagnosis and management of medical outpatients. Br Med J (1975) 9.18

Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther (1973) 5.23

Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J Pharmacol Exp Ther (1973) 4.40

Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology (1974) 4.32

A randomised trial of home-versus-hospital management for patients with suspected myocardial infarction. Lancet (1978) 4.12

Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J Pharmacol Exp Ther (1973) 3.89

Bronchiolitis obliterans organizing pneumonia. N Engl J Med (1985) 3.78

Epithelioid hemangioendothelioma of the liver: a clinicopathologic study of 137 cases. Cancer (1999) 3.68

Interim discharge summaries: how are they best delivered to general practitioners? Br Med J (Clin Res Ed) (1987) 3.64

Menopausal flushing: does oestrogen therapy make sense? Lancet (1976) 3.47

Self-poisoning: management of patients in Nottingham, 1976. Br Med J (1978) 3.24

Attachment of local health authority staff to general practices. 1. A study in three county boroughs with special reference to health visiting. Nurs Times (1968) 3.21

Therapeutic misadventures with acetaminophen: hepatoxicity after multiple doses in children. J Pediatr (1998) 3.02

Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA (1979) 2.99

Social influences on the sexual behavior of youth at risk for HIV exposure. Am J Public Health (1994) 2.95

Photocontrol of Hypocotyl Elongation in De-Etiolated Cucumis sativus L. : Long Term, Fluence Rate-Dependent Responses to Blue Light. Plant Physiol (1984) 2.81

Epithelioid hemangioendothelioma of the liver: a clinicopathologic and follow-up study of 32 cases. Hum Pathol (1984) 2.79

Hepatobiliary cystadenoma and cystadenocarcinoma. A light microscopic and immunohistochemical study of 70 patients. Am J Surg Pathol (1994) 2.72

Hepatic injury associated with ketoconazole therapy. Analysis of 33 cases. Gastroenterology (1984) 2.72

Benign tumors and pseudotumors of the gallbladder. Report of 180 cases. Arch Pathol (1970) 2.67

Type B hepatitis: the infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposure. N Engl J Med (1976) 2.67

Acetaminophen-induced hepatic injury: protective role of glutathione in man and rationale for therapy. Clin Pharmacol Ther (1974) 2.62

Accumulation and elimination of poliovirus by the eastern oyster. Am J Epidemiol (1966) 2.58

Randomised placebo-controlled trial comparing oxprenolol with disopyramide phosphate in immediate treatment of suspected myocardial infarction. Lancet (1980) 2.53

Development of chronic liver disease after acute non-A, non-B post-transfusion hepatitis. Role of gamma-globulin prophylaxis in its prevention. Gastroenterology (1977) 2.50

Development of a culturally, theoretically and developmentally based survey instrument for assessing risk behaviors among African-American early adolescents living in urban low-income neighborhoods. AIDS Educ Prev (1995) 2.48

Determination of bilirubin UDP-glucuronyl transferase activity in needle-biopsy specimens of human liver. Clin Chim Acta (1970) 2.39

Benign tumors of the liver. Med Clin North Am (1975) 2.38

Undifferentiated (embryonal) sarcoma of the liver: report of 31 cases. Cancer (1978) 2.37

Epithelioid hemangioendothelioma and related lesions. Semin Diagn Pathol (1986) 2.34

Isoniazid liver injury: clinical spectrum, pathology, and probable pathogenesis. Ann Intern Med (1976) 2.33

Randomised trial comparing propranolol with atenolol in immediate treatment of suspected myocardial infarction. Br Med J (1980) 2.32

Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. N Engl J Med (1978) 2.30

Risk of acute liver injury associated with the combination of amoxicillin and clavulanic acid. Arch Intern Med (1996) 2.29

Type B hepatitis after needle-stick exposure: prevention with hepatitis B immune globulin. Final report of the Veterans Administration Cooperative Study. Ann Intern Med (1978) 2.29

Guanethidine and related agents. 3. Antagonism by drugs which inhibit the norepinephrine pump in man. J Clin Invest (1970) 2.29

The molecular basis of sulfonylurea herbicide resistance in tobacco. EMBO J (1988) 2.28

Biliary cystadenoma and cystadenocarcinoma: report of 14 cases and review of the literature. Cancer (1977) 2.28

RNA binding domain of telomerase reverse transcriptase. Mol Cell Biol (2001) 2.27

Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology (1991) 2.25

Patients' views on their discharge from follow up in outpatient clinics: qualitative study. BMJ (1997) 2.25

Hepatic bilirubin udp-glucuronyl transferase activity in liver disease and gilbert's syndrome. N Engl J Med (1969) 2.21

Identification of titanium in human tissues: probable role in pathologic processes. Hum Pathol (1991) 2.21

Alcohollike liver disease in nonalcoholics. A clinical and histologic comparison with alcohol-induced liver injury. Gastroenterology (1988) 2.20

Effect of a pyrimidopyrimidine derivative on thrombus formation in the rabbit. Nature (1965) 2.19

Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease. JAMA (1994) 2.18

Is nursing any business of doctors? A simple guide to the "nursing process". Br Med J (Clin Res Ed) (1984) 2.17

The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization. J Clin Pathol (1978) 2.13

Long-term mortality and morbidity of transfusion-associated non-A, non-B, and type C hepatitis: A National Heart, Lung, and Blood Institute collaborative study. Hepatology (2001) 2.13

Early reporting of myocardial infarction: impact of an experiment in patient education. Br Med J (Clin Res Ed) (1982) 2.11

Hepatocellular carcinoma in cirrhotic and noncirrhotic livers. A clinico-histopathologic study of 804 North American patients. Am J Clin Pathol (1996) 2.10

Eosinophilic granuloma of the liver: a characteristic lesion with relationship to visceral larva migrans. Am J Surg Pathol (2001) 2.07

Aspirin-induced hepatotoxicity in patients with systemic lupus erythematosus. Ann Intern Med (1974) 2.04

Mesenchymal hamartoma of the liver: report of 30 cases and review of the literature. Pediatr Pathol (1984) 2.00

Sulfonamide hepatic injury. Review of the literature and report of a case due to sulfamethoxazole. N Engl J Med (1967) 1.97

Hepatoblastoma and hepatocarcinoma in infancy and childhood. Report of 47 cases. Cancer (1967) 1.97

Clear cell myomelanocytic tumor of the falciform ligament/ligamentum teres: a novel member of the perivascular epithelioid clear cell family of tumors with a predilection for children and young adults. Am J Surg Pathol (2000) 1.95

Transmission of hepatitis A virus among recently captured Panamanian owl monkeys. J Med Virol (1982) 1.94

Migration of coordinated cell clusters in mesenchymal and epithelial cancer explants in vitro. Cancer Res (1995) 1.92

Platelet reactivity and serum thromboxane B2 production in whole blood in gestational hypertension and pre-eclampsia. Br J Obstet Gynaecol (1991) 1.91

Acetaminophen-induced hepatic necrosis. 3. Cytochrome P-450-mediated covalent binding in vitro. J Pharmacol Exp Ther (1973) 1.90

Acetaminophen activation by human liver cytochromes P450IIE1 and P450IA2. Arch Biochem Biophys (1989) 1.89

The efficiency of specialist outreach clinics in general practice: is further evaluation needed? J Health Serv Res Policy (1997) 1.89

Bile duct adenoma. A study of 152 cases. Am J Surg Pathol (1988) 1.87

Effect of prostaglandin E1 on platelet behaviour in vitro and in vivo. Br Med J (1967) 1.85

Extracts of feverfew inhibit granule secretion in blood platelets and polymorphonuclear leucocytes. Lancet (1985) 1.84

Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical study. Cancer (1985) 1.82

An association between abo blood-group distribution and geographical differences in death-rates. Lancet (1977) 1.81

Hypersensitivity reaction to sulfasalazine with severe hepatotoxicity. Gastroenterology (1978) 1.80

Effect of dipyridamole on human platelet behaviour. Lancet (1965) 1.79

Plasma glutathione and glutathione disulfide in the rat: regulation and response to oxidative stress. J Pharmacol Exp Ther (1983) 1.79

Normal chest roentgenograms in chronic diffuse infiltrative lung disease. N Engl J Med (1978) 1.78

Injuries resulting when small children fall out of bed. Pediatrics (1977) 1.77

Increased incidence of isoniazid hepatitis in rapid acetylators: possible relation to hydranize metabolites. Clin Pharmacol Ther (1975) 1.75

Nodular transformation (nodular "regenerative" hyperplasia) of the liver. A clinicopathologic study of 30 cases. Hum Pathol (1981) 1.73

Oxidation of alpha-methyldopa and other catechols by cytochrome P-450-generated superoxide anion: possible mechanism of methyldopa hepatitis. Mol Pharmacol (1976) 1.73

Dexamethasone in acute stroke. Br Med J (1978) 1.73

Acetaminophen-induced hepatic necrosis. VI. Metabolic disposition of toxic and nontoxic doses of acetaminophen. Pharmacology (1974) 1.70

Xanthogranulomatous cholecystitis. Am J Surg Pathol (1981) 1.70

Association of hepatocellular carcinoma in North American patients with extrahepatic primary malignancies. Cancer (1994) 1.69

Is an information booklet for patients leaving hospital helpful and useful? BMJ (1989) 1.68

Antagonism of the antihypertensive action of guanethidine sulfate by desipramine hydrochloride. JAMA (1967) 1.67

What constitutes evidence on the dietary prevention of coronary heart disease? Cosy beliefs or harsh facts? Int J Cardiol (1984) 1.66

Recurrence risk of stillbirth in a second pregnancy. BJOG (2010) 1.64

Hepatocellular carcinoma and nodular regenerative hyperplasia: possible pathogenetic relationship. Am J Gastroenterol (1996) 1.62

Randomised double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet (1988) 1.62

The diagnosis of child sexual abuse. Am J Dis Child (1992) 1.59

The role of the interview in student selection. S Afr Med J (1978) 1.59

Efficacy of hepatitis B immune serum globulin after accidental exposure. Preliminary report of the Veterans Administration Cooperative Study. Lancet (1975) 1.59

Results of steroid-based therapy for the hepatitis C-autoimmune hepatitis overlap syndrome. Am J Gastroenterol (2001) 1.57

Autumn Books: Who needs Clinical Pharmacology? Br Med J (Clin Res Ed) (1984) 1.57

Hepatotoxicity: pathogenesis and therapeutic intervention. Clin Gastroenterol (1979) 1.57

"But will it help my patients with myocardial infarction?" The implications of recent trials for everyday country folk. Br Med J (Clin Res Ed) (1982) 1.55

Effect of aggregating agents on the electrophoretic mobility of human platelets. Br Med J (1966) 1.55